Stage-specific associations between beta blocker use and prognosis after colorectal cancer

Multiple Imputation UsingSASSoftware

(2015) Yang Yuan   Journal of Statistical Software

Beta-Blocker Drug Therapy Reduces Secondary Cancer Formation in Breast Cancer and Improves Cancer Specific Survival

(2015)   Oncotarget

Protection From Colorectal Cancer After Colonoscopy

(2013) Hermann Brenner et al.   ANNALS OF INTERNAL MEDICINE

Improved survival outcomes with the incidental use of beta-blockers among patients with non-small-cell lung cancer treated with definitive radiation therapy

(2013) H. M. Wang et al.   ANNALS OF ONCOLOGY

Beta blocker use and colorectal cancer risk

(2012) Lina Jansen et al.   CANCER

Impact of beta blockers on epithelial ovarian cancer survival

(2012) Elena S. Diaz et al.   GYNECOLOGIC ONCOLOGY

Use of β-blockers is associated with prostate cancer-specific survival in prostate cancer patients on androgen deprivation therapy

(2012) Helene Hartvedt Grytli et al.   PROSTATE

Stimulation of Host Bone Marrow Stromal Cells by Sympathetic Nerves Promotes Breast Cancer Bone Metastasis in Mice

(2012) J. Preston Campbell et al.   PLOS BIOLOGY

Beta blockers, norepinephrine, and cancer: an epidemiological viewpoint

(2012) P J Fitzgerald   Clinical Epidemiology

Treatment With β-Blockers and Reduced Disease Progression in Patients With Thick Melanoma

(2011) Vincenzo De Giorgi et al.   ARCHIVES OF INTERNAL MEDICINE

Benefit finding and post-traumatic growth in long-term colorectal cancer survivors: prevalence, determinants and associations with quality of life

(2011) L Jansen et al.   BRITISH JOURNAL OF CANCER

Does β-adrenoceptor blocker therapy improve cancer survival? Findings from a population-based retrospective cohort study

(2011) Sunil M. Shah et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

 -Blockers and Survival among Danish Patients with Malignant Melanoma: A Population-Based Cohort Study

(2011) S. Lemeshow et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Molecular Pathways: Beta-Adrenergic Signaling in Cancer: Figure 1.

(2011) Steven W. Cole et al.   CLINICAL CANCER RESEARCH

Beta Blockers and Breast Cancer Mortality: A Population- Based Study

(2011) Thomas I. Barron et al.   JOURNAL OF CLINICAL ONCOLOGY

Beta-Blocker Use Is Associated With Improved Relapse-Free Survival in Patients With Triple-Negative Breast Cancer

(2011) Amal Melhem-Bertrandt et al.   JOURNAL OF CLINICAL ONCOLOGY

Age-Specific Administration of Chemotherapy and Long-Term Quality of Life in Stage II and III Colorectal Cancer Patients: A Population-Based Prospective Cohort

(2011) L. Jansen et al.   ONCOLOGIST

The Sympathetic Nervous System Induces a Metastatic Switch in Primary Breast Cancer

(2010) E. K. Sloan et al.   CANCER RESEARCH

Is norepinephrine an etiological factor in some types of cancer?

(2008) Paul J. Fitzgerald   INTERNATIONAL JOURNAL OF CANCER